{"id":"W4405374985","doi":"10.1016/j.iotech.2024.100845","title":"102P A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma after progression on first-line lenvatinib combined with PD-1 inhibitor","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Hepatocellular carcinoma; Medicine; Oncology; Internal medicine; Second line; Line (geometry); First line; Sorafenib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002582678,0.0004715911,0.001393821,0.0009148853,0.0001097056,0.000007064619,0.0002928478,0.000461532,0.0002484003],"category_scores_gemma":[0.00006146189,0.0002762038,0.0002787985,0.001664731,0.0006562851,0.00004939382,0.0001775126,0.0003772965,0.000009441033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000397797,"about_ca_system_score_gemma":0.0004175922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003502093,"about_ca_topic_score_gemma":0.001495164,"domain_scores_codex":[0.9973235,0.0002044509,0.001022889,0.000626881,0.0003689727,0.0004533085],"domain_scores_gemma":[0.9975659,0.0004430743,0.0004332676,0.001239916,0.0002472981,0.00007059953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01067984,0.01163205,0.939401,0.0004321012,0.001140443,0.0008872969,0.001636781,0.000002813598,0.02126822,0.0002244482,0.00005613465,0.01263881],"study_design_scores_gemma":[0.02437248,0.1512819,0.1327964,0.001246019,0.001807334,0.0001302986,0.0007551555,0.0006362681,0.6807835,0.0001135671,0.005721225,0.0003558077],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897428,0.003387211,0.000004179972,0.001404409,0.0002787209,0.004336957,0.00004359153,0.0001677694,0.000634382],"genre_scores_gemma":[0.9975584,0.0001448343,0.0002615807,0.0000170126,0.00006278142,0.001042,0.00004566802,0.00007372069,0.0007939736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8066046,"threshold_uncertainty_score":0.999969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03585710363949379,"score_gpt":0.2980887263409522,"score_spread":0.2622316227014584,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}